$Paramount Global-B(PARA.US$ Paramount Global Shares Rise 2.8% Premarket After Report Barry Diller's IAC Explores Bid to Take Control of Co
1
1
$Paramount Global-B (PARA.US)$ Paramount Global (NASDAQ:PARA) rose 3.3% in after hours trading after a report that media mogul Barry Diller and his company IAC Inc. (IAC) are exploring a bid to take control of the entertainment giant.
IAC (IAC) has signed a non-disclosure agreement with National Amusements, Paramount's controlling shareholder, according to a New York Times report late Monday, which cited people familiar with the matter.
IAC (IAC) has signed a non-disclosure agreement with National Amusements, Paramount's controlling shareholder, according to a New York Times report late Monday, which cited people familiar with the matter.
1
$Paramount Global-B(PARA.US$ Paramount Global Leaders Are Having Discussions With a Number of Companies to Explore Merging Paramount+ - CNBC
2
2
$Paramount Global-B(PARA.US$ Warner Bros Discovery Shares off 2.8% at $7.23; CNBC Reports Warner Bros Interest in Merging Max and Paramount+ as Jv
1
$Paramount Global-B(PARA.US$ Paramount Global (NASDAQ:PARA) (NASDAQ:PARAA) is reportedly in discussions to merge just its money-losing streaming offering Paramount+ with a partner streamer -- and Warner Bros. Discovery (WBD) is again coming up as a potential joint-venture mate.
Paramount is talking with other industry companies about such a venture, CNBC reported, and along with WBD, those talks are said to have included Comcast (CMCSA), whose Peacock service is of a similar competitive scale ...
Paramount is talking with other industry companies about such a venture, CNBC reported, and along with WBD, those talks are said to have included Comcast (CMCSA), whose Peacock service is of a similar competitive scale ...
1
1
$NLS Pharmaceutics(NLSP.US$ NLS Pharmaceutics (NASDAQ:NLSP) said Friday it will undertake a registered direct offering to raise $0.79 million.
NLSP is -13.4% to $0.21.
The company said it has entered into a definitive agreement for the issuance and sale of 3.28 million common shares at $0.24 per share.
NLSP is -13.4% to $0.21.
The company said it has entered into a definitive agreement for the issuance and sale of 3.28 million common shares at $0.24 per share.
$NLS Pharmaceutics(NLSP.US$ NLS Pharmaceutics Annnounced Registered Direct Offering Of 3,277,750 Shares At $0.24/Share
1
$Paramount Global-B(PARA.US$ 121212holding holding and holding holding holding holding holding holding holding holding holding holding holding holding holding 💔
1
4
$Paramount Global-B(PARA.US$ buy buy buy and holding holding holding holding 1212
1
$Paramount Global-B(PARA.US$ holding holding holding holding holding holding holding holding holding holding holding holding holding holding holding holding holding holding the stock 💙
1